HERANTIS PHARMA OYJHERANTIS PHARMA OYJHERANTIS PHARMA OYJ

HERANTIS PHARMA OYJ

No trades
See on Supercharts

HRTIS fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Herantis Pharma Oyj engages in the research and development of biopharmaceutical products. It offers medicinal products such as Cis-UCA eye drops for dry eye, CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, Cis-UCA emulsion cream for atopic dermatitis, and CDNF for amyotrophic lateral sclerosis (ALS). The company was founded by Eero Hemminki Castren, Henri Juhani Huttunen, Heikki Rauvala, and Mart Saarma in 2008 and is headquartered in Espoo, Finland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
HRTIS has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company